Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	4-aminopyridine (Short Term)	0	11
Total, all-cause mortality	Placebo (Short Term)	0	11
Total, all-cause mortality	4-aminopyridine (Long Term)	0	11
Total, all-cause mortality	Placebo (Long Term)	0	10
Total, other adverse events	4-aminopyridine (Short Term)	9	11
Total, other adverse events	Placebo (Short Term)	4	11
Total, other adverse events	4-aminopyridine (Long Term)	11	11
Total, other adverse events	Placebo (Long Term)	3	10
Total, serious adverse events	4-aminopyridine (Short Term)	0	11
Total, serious adverse events	Placebo (Short Term)	0	11
Total, serious adverse events	4-aminopyridine (Long Term)	0	11
Total, serious adverse events	Placebo (Long Term)	0	10

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01645787/event-totals